• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTEGRA NEUROSCICENCS IMPLANTS SA OSVII LP TWO PIECE SHUNT SYSTEM WITH UNITIZED 11

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTEGRA NEUROSCICENCS IMPLANTS SA OSVII LP TWO PIECE SHUNT SYSTEM WITH UNITIZED 11 Back to Search Results
Catalog Number 909712P
Device Problems Device Inoperable (1663); Aspiration Issue (2883); Device Operates Differently Than Expected (2913)
Patient Problems No Consequences Or Impact To Patient (2199); No Known Impact Or Consequence To Patient (2692)
Event Date 10/16/2015
Event Type  malfunction  
Event Description
The valve was implanted using the standard implant technique.Following insertion of the shunt, the surgeon was unhappy with the profile of the antechamber and valve mechanism.The valve failed the patency test and no cerebrospinal fluid (csf) would be aspirated through the valve to the distal catheter.There was no patient injury.However, the event led to increase surgery time for 60 minutes.The patient was not harmed due to the increase of surgery time.The medical staff finished the procedure by implanting a competitor product.Patient outcome was good.
 
Manufacturer Narrative
Integra has completed their internal investigation on 01/04/2016.The investigation included: methods: evaluation of actual device ; review of device history records; review of complaints history.Results: the valve unit only was received.Distal catheter had been cut and the stopper plate was slightly displaced.The valve modulus was then removed from its silicone elastomer housing and observed under magnification.Brownish residues were found at the level of the diaphragm, in the seat lodging.Those residues and their location may explain the higher observed flow.The device history records of ref (b)(4), lot 0190293, valve sn (b)(4) were reviewed and did not reveal any anomaly.The batch was manufactured in april 2015 and included (b)(4) valves.No similar complaint was received for a product from this batch.The integra complaint database for the osv ii valves was reviewed for the last 3 years.The review indicated the rate of complaint reports for failure/obstruction during the implantation procedure is (b)(4) (basis of (b)(4) osv ii valves).Conclusion: the complaint is not verified by the device investigation: the valve is found patent.However, since residue were observed in the valve mechanism, it is possible that they first led to the valve obstruction during the implantation procedure, and then were slightly displaced during valve manipulations or decontamination, explaining the slight shift at the flow regulation stage.Each valve is pressure/flow tested at the end of the manufacturing process and valve (b)(4) was within specifications.The integra complaint database for the device was reviewed for the last 3 years.The review indicated the rate of complaint reports for failure/obstruction during the implantation procedure is (b)(4) (basis of (b)(4) osv ii valves).Valve obstruction is a known complication valve therapy: it may be related to debris released during the implantation procedure.The instructions for use recommend to aspirate 2 or 3ml of csf from the ventricular catheter to eliminate possible debris from the csf.No further investigation nor corrective action is therefore deemed required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OSVII LP TWO PIECE SHUNT SYSTEM WITH UNITIZED 11
Type of Device
OSVII
Manufacturer (Section D)
INTEGRA NEUROSCICENCS IMPLANTS SA
2905 route des dolines
2905 route des dolines
sophia antipolis F-069 21
FR  F-06921
Manufacturer (Section G)
INTEGRA NEUROSCICENCS IMPLANTS SA
2905 route des dolines
sophia antipolis F-069 21
FR   F-06921
Manufacturer Contact
rowena bunuan
311 enterprise drive
plainsboro, NJ 08536
6099362393
MDR Report Key5217906
MDR Text Key31143122
Report Number9612007-2015-00020
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K140722
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 10/20/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/11/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number909712P
Device Lot Number0000000190293
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/26/2015
Is the Reporter a Health Professional? No
Date Manufacturer Received01/04/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/01/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Age9 YR
-
-